Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components

v3.23.1
Balance Sheet Components
 12 Months Ended
Dec. 31, 2022
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2021 and 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2021     2022  
Prepaid directors and officers liability insurance premiums   $ 821     $ 476  
Prepaid preclinical services     885       1,554  
Other     126       159  
Total   $ 1,832     $ 2,189  

 

Property, plant and equipment as of December 31, 2021 and 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2021     2022  
Leasehold improvements   $       15     $       15  
Furniture and fixtures     14       14  
Subtotal     29       29  
Less accumulated depreciation     (1 )     (7 )
Net   $ 28     $ 22  

 

Accounts payable as of December 31, 2021 and 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2021     2022  
Trade accounts payable   $       713     $       846  
Credit card liability     29       46  
Total   $ 742     $ 892  

 

Accrued liabilities as of December 31, 2021 and 2022 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2021     2022  
Accrued labor costs   $ 691     $ 1,487  
Accrued drug development costs     369       228  
Other     152       522  
Total   $ 1,212     $ 2,237